Parathyroid hormone is a single chain polypeptide made up of 84 amino acids secreted by the parathyroid gland located near the thyroid gland.
Parathyroid hormone is a single chain polypeptide made up of 84 amino acids secreted by the parathyroid gland located near the thyroid gland. Inadequate secretion of parathyroid hormone results in the development of diseases related to bone such as osteoporosis, hypocalcaemia, and hyperphosphetemia. Parathyroid hormone controls the distribution of phosphate and calcium in the body.
Read Report Overview - https://www.transparencymarketresearch.com/parathyroid-hormone-market.html
Hypoparathyroidism is a condition, wherein parathyroid glands do not produce sufficient amount of parathyroid hormone (PTH). The disease is characterized by low level of calcium and high levels of phosphate in the blood. According to statistics by Verdict Media Limited., approximately 100,000 people in the U.S. are diagnosed with hyperparathyroidism.
Increase in incidence and prevalence of conditions related to the imbalance in the parathyroid hormone level in the body due to changing lifestyles, surge in R&D on the development of parathyroid hormone analogues, and improved diagnostic procedures for the detection of parathyroid hormone imbalance are projected to drive the global parathyroid hormone market during the forecast period. In April 2017, Shire plc received approval from the European Commission for Natpar (rhPTH[1-84]).
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=57732
It is the first recombinant human protein with the full length 84-amino acid sequence of endogenous parathyroid hormone (PTH). Moreover, hypoparathyroidism is a rare disease. Hence, the products developed for its treatment are getting orphan drugs designation, leading to increase in research and development in this therapy area. However, complicated process of product development, high cost of manufacturing, and increasingly stringent regulatory requirements are anticipated to restrain the market during the forecast period.
The global parathyroid hormone market can be segmented based on product type, indication, end-user, and region. In terms of product type, the parathyroid hormone market can be bifurcated into recombinant parathyroid hormones and parathyroid hormone analogues. The parathyroid hormone analogues segment includes teriparatide and abaloparatide.
Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_id=57732
Based on indication, the global parathyroid hormone market can be classified into hypoparathyroidism, osteoporosis, and postmenopausal bone complications. In terms of end-user, the parathyroid hormone market can be divided into hospitals, clinics, and others. The hospitals segment is anticipated to account for major parathyroid hormone market share during the forecast period. However, the clinics segment is likely to expand at the highest CAGR from 2018 to 2026 owing to rise in patient preference for clinics due to improved medical services, cleanliness, and favorable reimbursement scenario.
Based on region, the global parathyroid hormone market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is projected to dominate the global parathyroid hormone market owing to high incidence rate of hypoparathyroidism, increase in health care spending, rise in investment in research related to parathyroid hormone product development by players, and surge in new product approvals in the region. Europe is anticipated to be the second largest market for parathyroid hormone in terms of revenue during the forecast period. Presence of large geriatric population is expected to propel the market in the region. The parathyroid hormone market in Asia Pacific is likely to expand at the highest CAGR due to economy growth and rise in health care expenditure in the developing countries.
Pre Book Parathyroid Hormone Market Report at https://www.transparencymarketresearch.com/checkout.php?rep_id=57732<ype=S
Key players operating in the global parathyroid hormone market include Shire plc, Eli Lilly and Company, Physicians Total Care, Inc., and Radius Health, Inc. Large number of players are participating in the clinical trials of the parathyroid hormone products including Pfizer, Inc. Ascendis Pharma A/S, Entera Bio Ltd., and Extend Biosciences, Inc.
Browse more Reports by Transparency Market Research:
Health Care Interoperability Solutions Market: Health care is experiencing a massive revolution as technology is widely used to engage patients, consumers, and caregivers, provide real-time information, and support care delivery with better use of data and analytics. Health care interoperability solutions are extensively employed in health care facilities, leading to rapid developments in the global Health care interoperability solutions market.
Specialty Active Pharmaceutical Ingredients Market: The global specialty active pharmaceutical ingredients market is expected to witness a promising growth opportunities in the coming years of the forecast period. With growing number of patent expiry of several different branded drugs, the market is projected witness growth in sales, particularly across the US and Europe.
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.
Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/